Skip to content
Screener

Bio-Rad Laboratories BIO Clinical Diagnostics — Net Sales

Other segment segments

Life Science
$228.5M0.0%
All Other Segments
$0-100%

Similar metrics at other companies

Abbott logo
ABTDiagnostic Products — Net Sales
$3.09B+42.3%
Medline, Inc. logo
MDLNLaboratory and Diagnostics — Net Sales
$248M+12.2%
Motorola Solutions, Inc. logo
MSIMission Critical Networks (MCN) — Net Sales
$1.97B+3.5%
Central Garden & Pet Company logo
CENTPet — Net Sales
$400.5M-18.7%
CNH Industrial N.V. logo
CNHNet Sales — Net Sales
$2.6B+0.6%
General Mills logo
GISPet — Net Sales
$746.6M+5.8%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.3B+30.0%
Enterprise value$9.78B+19.3%
P/E55.1×+32.7×
P/S3.6×+0.8×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000012208-26-000035
Life ScienceClinical Diagnostics
2026$228.5$363.6
2025$228.6$356.8
2026$100.9$181.8
2025$100.2$179.2
2026$127.6$181.8
2025$128.4$177.6
2026$18.3$22.6
2025$17.0$21.1

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's clinical diagnostics — net sales?
Bio-Rad Laboratories (BIO) reported clinical diagnostics — net sales of $363.6M in Q1 2026.
How has Bio-Rad Laboratories's clinical diagnostics — net sales changed year-over-year?
Bio-Rad Laboratories's clinical diagnostics — net sales increased by 1.9% year-over-year, from $356.8M to $363.6M.
What is the long-term trend for Bio-Rad Laboratories's clinical diagnostics — net sales?
Over 4 years (2021 to 2025), Bio-Rad Laboratories's clinical diagnostics — net sales has grown at a 0.8% compound annual growth rate (CAGR), from $1.52B to $1.56B.
What does clinical diagnostics — net sales mean?
Total revenue generated from the sale of clinical diagnostic products, systems, and quality controls, net of returns, allowances, and discounts. This is the primary top-line metric for the diagnostics business unit.

Ask your AI about Bio-Rad Laboratories's clinical diagnostics — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude